Intended Use

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion within one week of head injury in patients 5 through 67 years of age in conjunction with a standard neurological assessment of concussion.

Technology

The device consists of an integrated stand with an eye-tracking camera that uses infrared illumination to capture eye movement data at 500 frames per second for each eye while the patient watches a predefined video stimulus. The software processes 220 seconds of binocular gaze data, discards initial and final segments, applies blink detection and normalization, and calculates a score (0-20) indicating abnormal eye movement patterns associated with concussion.

Performance

Performance testing included software verification and validation, clinical study with 282 subjects assessing sensitivity (80.4%) and specificity (66.1%) against a clinical reference standard for concussion, test-retest reliability analysis showing 79.3% equivalence, and safety testing including biocompatibility, electromagnetic compatibility, and light hazard assessments. No device-related adverse events were reported.

Device Timeline

  • 1

    Submission

    12/22/2017

    1 year
  • 2

    FDA Approval

    12/28/2018

Other devices from Oculogica, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.